Innate Pharma S.A. (NASDAQ:IPHA) Q3 2025 Earnings Call Transcript November 13, 2025
Innate Pharma S.A. beats earnings expectations. Reported EPS is $-0.24551, expectations were $-0.32845.
Operator: Ladies and gentlemen, thank you for joining us, and welcome to the Innate Pharma Third Quarter 2025 Business Update and Financial Results. [Operator Instructions] I will now hand the conference over to Stephanie Cornen, Vice President, Investor Relations, Communication, and Commercial Strategy at...
